IN202411028038A - - Google Patents

Download PDF

Info

Publication number
IN202411028038A
IN202411028038A IN202411028038A IN202411028038A IN202411028038A IN 202411028038 A IN202411028038 A IN 202411028038A IN 202411028038 A IN202411028038 A IN 202411028038A IN 202411028038 A IN202411028038 A IN 202411028038A IN 202411028038 A IN202411028038 A IN 202411028038A
Authority
IN
India
Application number
IN202411028038A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN202411028038A priority Critical patent/IN202411028038A/en
Priority to PCT/US2025/022781 priority patent/WO2025212798A1/en
Publication of IN202411028038A publication Critical patent/IN202411028038A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
IN202411028038A 2024-04-04 2024-04-04 IN202411028038A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN202411028038A IN202411028038A (enExample) 2024-04-04 2024-04-04
PCT/US2025/022781 WO2025212798A1 (en) 2024-04-04 2025-04-02 Lyophilized centhaquine citrate injection formulation and a method for the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202411028038A IN202411028038A (enExample) 2024-04-04 2024-04-04

Publications (1)

Publication Number Publication Date
IN202411028038A true IN202411028038A (enExample) 2025-05-23

Family

ID=97268162

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202411028038A IN202411028038A (enExample) 2024-04-04 2024-04-04

Country Status (2)

Country Link
IN (1) IN202411028038A (enExample)
WO (1) WO2025212798A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025212798A1 (en) * 2024-04-04 2025-10-09 Pharmazz, Inc. Lyophilized centhaquine citrate injection formulation and a method for the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US20150250782A1 (en) * 2012-08-31 2015-09-10 Pharmazz, Inc. Methods and Compositions for Hypotensive Resuscitation
CN110022857A (zh) * 2016-11-18 2019-07-16 艾库里斯抗感染治疗有限公司 基于改性环糊精和酸化剂的脒取代β-内酰胺化合物的新制剂、其制备及作为抗微生物药物组合物的用途
CN112469474A (zh) * 2018-05-03 2021-03-09 美国中西部大学 出血和centhaquin引起的复苏后内皮素受体的变化
IN202411028038A (enExample) * 2024-04-04 2025-05-23

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025212798A1 (en) * 2024-04-04 2025-10-09 Pharmazz, Inc. Lyophilized centhaquine citrate injection formulation and a method for the same

Also Published As

Publication number Publication date
WO2025212798A1 (en) 2025-10-09

Similar Documents

Publication Publication Date Title
BR102024017758A2 (pt) Derivado piridil-tiazolidinona jc-21a com atividade fungicida frente candida auris e toxicidade dérmica em ratos
BR102024017432A2 (pt) Dispositivo simulador para treinamento de cuidados médicos
CN308784881S (zh) 皮草外套（yr329）
CN308734575S (zh) 分体壁挂式空调器(q_f_gcc1)
CN308708442S (zh) 鞋底（双层蜘蛛网）
CN308979990S (zh) 汽车腰靠（3）
CN308833054S (zh) 梳妆台
CN308777120S (zh) 手机掌纹掌静脉识别图形用户界面
CN308727021S (zh) 录音笔
CN308408152S (zh) 面料（7891）
CN308403600S (zh) 面料（bmhq27）
CN308403607S (zh) 面料（ly-20252）
CN308544201S (zh) 圆碗（洱海m2905）
CN308403154S (zh) 皮草外套（双面穿f-31060）
CN308693344S (zh) 手机壳（防身）
CN308408807S (zh) 咖啡杯（kst-011）
CN308502287S (zh) 可折叠园艺植物垫
CN308412684S (zh) 床（6012）
CN308412675S (zh) 护理床（混合）
CN308403999S (zh) 转角置物架（吸盘波纹）
CN308412298S (zh) 箱包（彝族文化）
CN308412951S (zh) 桌脚
CN308408758S (zh) 壶
CN308403985S (zh) 安全柜
CN308408505S (zh) 电视柜（2264,2265）